RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Failure of TAK442 to Meet the Primary End-point in a Phase II Study Underlines the Challenging Clinical Development Environment for Anticoagulants in Acute Coronary Syndromes
Nov 2010 - 5 pages - $500
Acute Coronary Syndromes Therapy Area Pipeline Report
Nov 2010 - 329 pages - $1,495
Acute Coronary Syndromes - Pipeline Review, Q1 2011
Feb 2011 - 62 pages - $500
Epidemiology: Acute Coronary Syndrome - Now affecting primarily the oldest populations
Jul 2011 - 46 pages - $3,800
Acute Coronary Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Dec 2010 - 49 pages - $2,000
Cardiovascular Biomarkers: Players, products and prospects (Volume III)
Aug 2008 - 120 pages - $1,040
Acute Coronary Syndrome - Pipeline Review, H2 2011
Sep 2011 - 106 pages - $500
Coronary Artery Disease Therapy Area Pipeline Report
Nov 2010 - 174 pages - $1,495
Cyclacel Pharmaceuticals Inc. - Product Pipeline Review - Q4 2010
Nov 2010 - 44 pages - $500
The Cardiovascular Market Outlook to 2016
Jun 2011 - 160 pages - $3,835
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us